Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.93 USD | +2.64% |
|
-3.41% | +11.08% |
| 07-20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.86B | - | - | - | - | - |
| 56.19B | |||||
| 54.83B | |||||
| 22.7B | - | ||||
| 23.04B | - | ||||
| 20.23B |
Select your edition
All financial news and data tailored to specific country editions
